Michael P Lisanti
Overview
Explore the profile of Michael P Lisanti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
422
Citations
28904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larrea Murillo L, Sugden C, Ozsvari B, Moftakhar Z, Hassan G, Sotgia F, et al.
Cells
. 2025 Jan;
13(24.
PMID: 39768151
Cancer stem cells (CSCs) account for 0.01 to 2% of the total tumor mass; however, they play a key role in tumor progression, metastasis and resistance to current cancer therapies....
2.
Mauro-Lizcano M, Di Pisa F, Larrea Murillo L, Sugden C, Sotgia F, Lisanti M
Cell Death Dis
. 2024 Oct;
15(10):745.
PMID: 39394145
Here, we examined the potential role of mitochondrial DNA (mtDNA) levels in conveying aggressive phenotypes in cancer cells, using two widely-used breast cell lines as model systems (MCF7[ER+] and MDA-MB-231[ER-])....
3.
Mauro-Lizcano M, Sotgia F, Lisanti M
Aging (Albany NY)
. 2024 Jun;
16(11):9334-9349.
PMID: 38834039
Mitophagy is a selective form of autophagy which permits the removal of dysfunctional or excess mitochondria. This occurs as an adaptative response to physiological stressors, such as hypoxia, nutrient deprivation,...
4.
Toth F, Moftakhar Z, Sotgia F, Lisanti M
Cells
. 2024 May;
13(10.
PMID: 38786063
Although cellular senescence was originally defined as an irreversible form of cell cycle arrest, in therapy-induced senescence models, the emergence of proliferative senescence-escaped cancer cells has been reported by several...
5.
Fiorillo M, Ricci E, Fava M, Longobucco C, Sotgia F, Rizza P, et al.
Cells
. 2023 Dec;
12(24).
PMID: 38132097
Tamoxifen-resistant breast cancer cells (TamR-BCCs) are characterized by an enhanced metabolic phenotype compared to tamoxifen-sensitive cells. FoxO3a is an important modulator of cell metabolism, and its deregulation has been involved...
6.
Sebestyen A, Lisanti M, Ozsvari B
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001707
Metabolic reprogramming is one of the main hallmarks of cancer [...].
7.
Bonuccelli G, Brooks D, Shepherd S, Sotgia F, Lisanti M
Aging (Albany NY)
. 2023 Nov;
15(21):11764-11781.
PMID: 37950722
Aging is a continuous degenerative process caused by a progressive decline of cell and tissue functions in an organism. It is induced by the accumulation of damage that affects normal...
8.
Kaur B, Sohrabi Y, Achreja A, Lisanti M, Martinez-Outschoorn U
Front Oncol
. 2023 Jan;
12:1126913.
PMID: 36713555
No abstract available.
9.
Mauro-Lizcano M, Sotgia F, Lisanti M
Aging (Albany NY)
. 2022 Dec;
14(24):9877-9889.
PMID: 36566021
Cancer stem cells (CSCs) are responsible for cancer recurrence, treatment failure and metastatic dissemination. As such, the elimination of CSCs represents one of the most important approaches for the future...
10.
Bonuccelli G, Sotgia F, Lisanti M
Aging (Albany NY)
. 2022 Dec;
14(23):9466-9483.
PMID: 36455875
Here, we report the identification of key compounds that effectively inhibit the anchorage-independent growth and propagation of cancer stem cells (CSCs), as determined via screening using MCF7 cells, a human...